Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Vyloy

(VY-loy)
A drug used with chemotherapy containing fluoropyrimidine and platinum to treat adults with gastric (stomach) cancer or gastroesophageal junction cancer that has the CLDN18.2 protein, is HER2-negative, and has spread to other parts of the body or cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Vyloy binds to CLDN18.2, which is found on the surface of some cancer cells. This may help keep cancer cells from growing and may kill them. It is a type of monoclonal antibody. Also called zolbetuximab.
More Information
Search NCI's Dictionary of Cancer Terms